DA32 Life Science Tech Acquisition Corp. (DALS)
| Market Cap | 248.81M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 25.65M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 652 |
| Open | 9.74 |
| Previous Close | 9.84 |
| Day's Range | 9.70 - 9.70 |
| 52-Week Range | 9.70 - 10.19 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About DALS
DA32 Life Science Tech Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. In coming together as co-sponsors of DA32, Deerfield Management, ARCH Venture Partners and Section 32 aim to leverage their complementary capabilities and networks in order to acquire, merge with and grow a promising life science technology opportunity. We intend to focus our search for business combin...
News
DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pri...
NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price of ...
DA32 Life Science Tech Acquisition IPO Registration Document (S-1)
DA32 Life Science Tech Acquisition Corp. has filed to go public with an IPO on the NASDAQ.